sábado, 15 de octubre de 2016

Multiagency Funding To Assist With Opioid Crisis in Rural U.S. Regions

Multiagency Funding To Assist With Opioid Crisis in Rural U.S. Regions

SAMHSA Logo

Multiagency Funding Announcement To Assist With Opioid Crisis in Rural U.S. Regions

A new federal funding opportunity was announced to help find solutions to the opioid use and overdose crisis in the nation's rural regions. It includes a focus on coal-impacted counties within Appalachia, as well as rural communities in other parts of the country. This initiative will support comprehensive, integrated approaches to prevent opioid injection and its consequences, including substance use disorder, overdose, HIV and hepatitis C virus infection, along with associated conditions, such as hepatitis B virus infection and sexually transmitted diseases. These projects will work with state and local communities to develop best practice responses to opioid injection epidemics that can be implemented by public health systems in the nation's rural communities.
The request for applications (RFA) titled, "HIV, HCV, and Related Comorbidities in Rural Communities Affected by Opioid Injection Drug Epidemics in the United States: Building Systems for Prevention, Treatment, and Control (UG3/UH3)," is being funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, in collaboration with the Appalachian Regional Commission, a federal−state partnership; the Centers for Disease Control and Prevention (CDC); and SAMHSA.
Learn More About This Funding Opportunity
An accompanying RFA, co-funded by NIDA and CDC, titled "Hepatitis C Virus (HCV) Advanced Molecular Detection in Support of Systems for Prevention, Treatment, and Control of HIV, HCV, and Related Comorbidities in Rural Communities Affected by Opioid Injection Drug Epidemics in the United States (U24)," will support a Center for HCV next-generation sequencing using Global Hepatitis Outbreak and Surveillance Technology.
Learn More About This Funding Opportunity